Prosecution Insights
Last updated: April 19, 2026

Orionis Biosciences Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17786162 BIFUNCTIONAL AGENTS FOR PROTEIN RECRUITMENT AND/OR DEGRADATION RZECZYCKI, PHILLIP MATTHEW 1625 Final Rejection Jun 16, 2022
17786161 COMPOUNDS MODULATING PROTEIN RECRUITMENT AND/OR DEGRADATION YOUNGBLOOD, WILLIAM JUSTIN 1629 Non-Final OA Jun 16, 2022
17763344 PD-L1 TARGETED CHIMERIC PROTEINS AND USES THEREOF HOPKINS, SAMANTHA LAKE 1641 Final Rejection Mar 24, 2022

Managing Orionis Biosciences Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month